Latest News of ENIA
Palma Development tops out Serenia Living development in Dubai
By Yahoo! Finance |
2 days ago
Palma Development achieves a construction milestone by topping out Serenia Living, a luxury beachfront project in Dubai. The development consists of four towers with 226 exclusive apartments, offering...
AbbVie's stock plummets over 12% after schizophrenia drug flops in Phase II trials
By Yahoo! Finance |
1 week ago
AbbVie's stock plummeted by 12% after its anti-psychotic drug, emraclidine, failed to meet primary endpoints in Phase II trials for schizophrenia treatment....
Bristol Myers's stock soars after AbbVie's schizophrenia-drug trial disappoints
By MarketWatch |
1 week ago
Bristol Myers Squibb's stock rose by 12.5% following AbbVie's announcement of disappointing trial results for their new schizophrenia drug, causing AbbVie's shares to drop by 12.4%....
-
AbbVie Stock Tumbles on Failed Schizophrenia Drug Studies. Bristol Myers Jumps.
By MarketWatch | 1 week agoAbbVie's stock dropped significantly as their schizophrenia drug, emraclidine, failed to show significant improvement in two Phase 2 trials. The drug did not meet the primary endpoint of demonstrating...
-
AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials
By Yahoo! Finance | 1 week agoAbbVie Inc. faces a setback as its drug for schizophrenia failed in trials, causing shares to drop significantly. This news benefits Bristol Myers Squibb Co., which recently gained approval for a new ...
-
Xenia Hotels & Resorts Sees IBD RS Rating Climb To 74
By Investor's Business Daily | 2 weeks agoIBD's Relative Strength Rating measures market leadership on a scale from 1 to 99, indicating a stock's price performance compared to others. It's crucial for spotting potential winners early on. Anal...
-
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
By Forbes | 2 weeks agoThe newly approved schizophrenia drug, Cobenfy, offers a novel treatment approach targeting cholinergic receptors. Despite its potential benefits, challenges like high cost and insurance coverage rest...
-
Teva's long-lasting schizophrenia injectable shines in Phase III
By Yahoo! Finance | 2 weeks agoTeva Pharmaceuticals' TEV-479 (olanzapine) showed significant improvements in schizophrenia symptoms and quality of life in a Phase III trial. The study revealed positive results across different dose...
-
The Guardian view on Kemi Badenoch: a right turn reveals a party still in denial | Editorial
By The Guardian | 2 weeks agoKemi Badenoch, the new Conservative leader, offers a neo-Thatcherite approach, aiming to steer the party towards culture wars. Despite her rapid rise, her traditional views may face challenges in the ...
-
Spain's apocalyptic floods show undeniable truths: the climate crisis is getting worse and Big Oil is killing us | Jonathan Watts
By The Guardian | 2 weeks agoThe recent devastating floods in Spain highlight the urgent need for action on climate change at Cop29. Instead of normalizing disasters, global leaders must prioritize halting fossil fuel use to stab...
-
A promising schizophrenia drug showed mixed results. What does that mean for patients?
By AP NEWS | 3 weeks agoA new schizophrenia drug, Cobenfy, shows promise with minimal side effects and weight loss benefits. However, high dropout rates in trials highlight challenges in treating schizophrenia. Patients' exp...
-
Zai Lab presents positive outcomes from KarXT Phase III trial for schizophrenia
By Yahoo! Finance | 3 weeks agoZai Lab's Phase III trial of KarXT for schizophrenia in China showed positive outcomes, meeting primary and secondary endpoints. The trial demonstrated the potential of KarXT as a new treatment option...
-
Evertune is building marketing analytics tools for LLMs. Check out the pitch deck it used to launch from stealth with $4 million in seed funding from Eniac.
By Business Insider | 3 weeks agoEvertune, a startup with $4 million seed funding, offers a brand analytics platform focusing on AI models' perception of brands. It aims to help companies understand consumer recommendations and compa...
-
Two hurricanes stir up voter backlash to Florida Republicans' climate denialism
By The Guardian | 3 weeks agoYoung voters in Florida are increasingly concerned about the climate crisis after hurricanes Helene and Milton hit the state. The disasters have sparked a backlash against politicians who have denied ...
-
Maher, Megyn Kelly spar over potential denialism after Election Day
By The Hill | 3 weeks agoBill Maher and Megyn Kelly debated on potential denialism after Election Day. While Maher criticized Trump's behavior, Kelly argued Democrats could also engage in denialism if Harris loses. Maher refu...